- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05080387
Neopterin in Acute Coronary Syndrome Patients
February 14, 2022 updated by: Mina Khairy Alyshaa Gorgy, Assiut University
Measurement of neopterin in ACS patients
Study Overview
Status
Recruiting
Intervention / Treatment
Detailed Description
- Detect level of neopterin in ACS patients to detect whether there is relation or not between ACS and neopterin
- Detection of relation between neopterin and cardiac enzymes as CK and troponine in ACS patients
- Detect relation between neopterin level and in hospital events
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Mina Khairy Alyshaa Gorgy, Resident
- Phone Number: 01227386406
- Email: Minakhairy1995@gmail.com
Study Contact Backup
- Name: Yehia Taha keshik, Prof. Doctor
- Phone Number: 01223971269
Study Locations
-
-
-
Assiut, Egypt, AssiutU
- Recruiting
- Assiut University
-
Contact:
- Yehia Taha keshik, Prof . Doctor
- Phone Number: 01223971269
-
Contact:
- Magdy Ibrahim El desoky, Lecturer
- Phone Number: 01279950400
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
All patients of sample size admitted to cardiology department with ACS.
Description
Inclusion Criteria:
All patient of sample size admitted to cardiology departmentof Assiut university hospital with :
- Acute typical chest pain
- Positive cardiac enzymes
- ECG show recent ischemic changes
- ECHO show SWMA
Exclusion Criteria:
- Patients not fulfill inclusion criteria.
- Patients with other diseases which may cause increase of neopterin level as viral infections, intracellular bacteria or parasites infections, certain malignancies, allograft rejection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
To detect whether there is association between neopterin and ACS or not
Time Frame: 72 hours
|
To detect whether there is association between neopterin and ACS or not
|
72 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Detection of relation between neopterin and cardiac enzymes as CK and troponine in ACS and detection of relation between neopterin level and in hospital events
Time Frame: 72 hours
|
Detection of relation between neopterin and cardiac enzymes as CK and troponine in ACS and detection of relation between neopterin level and in hospital events
|
72 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Magdy Ibrahim Aldesowky, Lecturer, Assiut University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
November 1, 2022
Primary Completion (Anticipated)
October 1, 2023
Study Completion (Anticipated)
October 1, 2024
Study Registration Dates
First Submitted
October 5, 2021
First Submitted That Met QC Criteria
October 5, 2021
First Posted (Actual)
October 15, 2021
Study Record Updates
Last Update Posted (Actual)
February 15, 2022
Last Update Submitted That Met QC Criteria
February 14, 2022
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Neopterin
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
IPD Plan Description
Share if participants agree
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.